Company Description
Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on the business side of the U.S. healthcare market. The company describes itself as an industry leader in healthcare commercial intelligence, providing information and insights that help organizations make smarter, faster and more strategic decisions across the healthcare ecosystem.
According to the company, the healthcare market is complex, and its data is intended to make that market clearer for customers. Definitive Healthcare states that it transforms data, analytics and expertise into healthcare commercial intelligence so clients can uncover the right markets, opportunities and people and shape tomorrow’s healthcare industry.
Business model and platform
Definitive Healthcare operates a SaaS-based healthcare commercial intelligence platform. As described in its public materials, the platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the United States. The company notes that its products and solutions create new paths to commercial success in the healthcare market, helping companies identify where to go next.
The platform uses deep analytics and data science to help customers develop data-driven strategic decisions. Examples cited by the company include finding new markets to enter, building go-to-market strategies, accessing tactical information to target appropriate decision makers, and improving win rates with detailed contextual information.
Definitive Healthcare reports that it derives substantially all of its revenue from subscription fees for access to its platform and stand-ready support. This subscription model aligns with its description of SaaS products and solutions that customers use on an ongoing basis.
End markets and use cases
Across its disclosures and press releases, Definitive Healthcare highlights that it serves a range of healthcare-related end markets. It references customer wins with organizations such as medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms, and healthcare advertising agencies. These examples illustrate how different types of organizations use its data, insights and integrations to support their critical business use cases.
The company emphasizes that its data and analytics help clients:
- Uncover the right markets and opportunities in the healthcare sector
- Identify and engage the right people and decision makers
- Support go-to-market execution and sales targeting
- Inform diligence and investment strategies in healthcare
- Support service line expansion, physician recruitment and telemedicine growth for providers
Industry positioning and sector classification
Definitive Healthcare describes itself as a healthcare commercial intelligence and healthcare market data and analytics company. Based on the provided classification, it operates within the Professional, Scientific, and Technical Services sector and the industry category of Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology).
The company’s focus is on the information and analytics needs of the healthcare market rather than on direct patient care or the development of drugs or devices. Its role, as described in its own materials, is to cut through the noise of the healthcare market and deliver insights that organizations and companies can use to make more informed commercial decisions.
Geographic focus
Definitive Healthcare’s platform is described as providing information on the healthcare ecosystem in the United States. The company also notes that it derives a majority of its revenue from the United States, underscoring that its commercial intelligence and data assets are primarily oriented around the U.S. healthcare market.
Stock information and corporate structure
Definitive Healthcare Corp. is incorporated in Delaware and its common stock trades on the NASDAQ under the ticker symbol DH. SEC filings list its corporate name as Definitive Healthcare Corp. and confirm its status as a Delaware corporation.
Management, governance and disclosures
Through its SEC filings, the company discloses changes in its board and executive leadership, such as the resignation of directors, changes in committee roles, and adjustments to executive positions. It also reports inducement equity awards granted to senior leaders under its inducement plan, consistent with Nasdaq Listing Rule 5635(c)(4). These disclosures provide insight into how Definitive Healthcare manages executive compensation and leadership transitions.
The company regularly issues earnings press releases and files related Form 8-K reports to furnish financial results for its quarters and to provide financial guidance. These communications include discussions of non-GAAP financial measures such as Adjusted EBITDA, Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Unlevered Free Cash Flow, along with explanations of why management uses these metrics to evaluate performance.
Financial communication and non-GAAP metrics
In its earnings releases, Definitive Healthcare explains that it uses non-GAAP financial measures to focus on the performance of its core operations and to facilitate comparisons to historical periods and to other companies. The company provides definitions for metrics such as:
- Adjusted EBITDA and Adjusted EBITDA Margin
- Adjusted Gross Profit and Adjusted Gross Margin
- Adjusted Operating Income
- Adjusted Net Income and Adjusted Net Income Per Diluted Share
- Unlevered Free Cash Flow
It also notes that these measures are supplemental, are not prepared in accordance with U.S. GAAP, and should not be considered substitutes for GAAP measures like net income, loss from operations, or cash provided by operating activities.
Investor communications and events
Definitive Healthcare frequently participates in investor conferences and hosts quarterly earnings calls and webcasts. The company announces the timing of these events in press releases and makes live audio webcasts available. It also states that it intends to use its website as a distribution channel for material company information, and that financial and other important information regarding the company is routinely posted and accessible there.
Status and continuity
Recent press releases and Form 8-K filings show that Definitive Healthcare continues to operate as a publicly traded company on NASDAQ under the symbol DH, reporting quarterly financial results, issuing financial guidance and making leadership and compensation disclosures. There is no indication in the provided materials of delisting, deregistration, bankruptcy, or completed merger transactions.
Stock Performance
Definitive Healthcare (DH) stock last traded at $1.13, up 11.06% from the previous close. Over the past 12 months, the stock has lost 59.5%. At a market capitalization of $104.4M, DH is classified as a micro-cap stock with approximately 104.5M shares outstanding.
Latest News
Definitive Healthcare has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, conferences. View all DH news →
SEC Filings
Definitive Healthcare has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DH SEC filings →
Financial Highlights
Definitive Healthcare generated $241.5M in revenue over the trailing twelve months, retaining a 75.9% gross margin, operating income reached -$224.3M (-92.9% operating margin), and net income was -$138.9M, reflecting a -57.5% net profit margin. Diluted earnings per share stood at $-1.30. The company generated $53.8M in operating cash flow. With a current ratio of 1.64, the balance sheet reflects a strong liquidity position.
Upcoming Events
Graboske RSU initial vesting
First RSU vesting
RSU vesting schedule
Quarterly RSU vesting
Definitive Healthcare has 5 upcoming scheduled events. The next event, "Graboske RSU initial vesting", is scheduled for April 1, 2026 (in 9 days). Investors can track these dates to stay informed about potential catalysts that may affect the DH stock price.
Short Interest History
Short interest in Definitive Healthcare (DH) currently stands at 2.4 million shares, up 5.7% from the previous reporting period, representing 8.7% of the float. Over the past 12 months, short interest has decreased by 34.8%. The 7.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Definitive Healthcare (DH) currently stands at 7.6 days, up 45.1% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 88.5% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 2.1 to 17.2 days.
DH Company Profile & Sector Positioning
Definitive Healthcare (DH) operates in the Health Information Services industry within the broader Services-prepackaged Software sector and is listed on the NASDAQ.
Investors comparing DH often look at related companies in the same sector, including Talkspace Inc (TALK), National Resh Corp (NRC), Optimizerx Corp (OPRX), So-Young Intl (SY), and Spok Hldgs Inc (SPOK). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DH's relative position within its industry.